South Korea · Delayed Price · Currency is KRW Daewoong Pharmaceutical Statistics
Total Valuation
KRX:069620 has a market cap or net worth of KRW 1.52 trillion. The enterprise value is 2.25 trillion.
| Market Cap | 1.52T |
| Enterprise Value | 2.25T |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
KRX:069620 has 11.51 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Current Share Class | 11.51M |
| Shares Outstanding | 11.51M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.39% |
| Owned by Institutions (%) | 23.85% |
| Float | 5.39M |
Valuation Ratios
The trailing PE ratio is 20.27 and the forward PE ratio is 10.30. KRX:069620's PEG ratio is 0.17.
| PE Ratio | 20.27 |
| Forward PE | 10.30 |
| PS Ratio | 1.02 |
| PB Ratio | 1.60 |
| P/TBV Ratio | 3.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 15.84 |
| PEG Ratio | 0.17 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.38, with an EV/FCF ratio of -84.65.
| EV / Earnings | 29.95 |
| EV / Sales | 1.51 |
| EV / EBITDA | 11.38 |
| EV / EBIT | 15.21 |
| EV / FCF | -84.65 |
Financial Position
The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.81.
| Current Ratio | 1.11 |
| Quick Ratio | 0.59 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | 3.50 |
| Debt / FCF | -28.93 |
| Interest Coverage | 14.33 |
Financial Efficiency
Return on equity (ROE) is 8.12% and return on invested capital (ROIC) is 6.61%.
| Return on Equity (ROE) | 8.12% |
| Return on Assets (ROA) | 5.33% |
| Return on Invested Capital (ROIC) | 6.61% |
| Return on Capital Employed (ROCE) | 11.54% |
| Revenue Per Employee | 905.29M |
| Profits Per Employee | 45.68M |
| Employee Count | 1,644 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 2.64 |
Taxes
In the past 12 months, KRX:069620 has paid 9.10 billion in taxes.
| Income Tax | 9.10B |
| Effective Tax Rate | 10.61% |
Stock Price Statistics
The stock price has decreased by -3.98% in the last 52 weeks. The beta is 0.51, so KRX:069620's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -3.98% |
| 50-Day Moving Average | 140,216.00 |
| 200-Day Moving Average | 137,749.50 |
| Relative Strength Index (RSI) | 38.29 |
| Average Volume (20 Days) | 40,490 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:069620 had revenue of KRW 1.49 trillion and earned 75.10 billion in profits. Earnings per share was 6,526.75.
| Revenue | 1.49T |
| Gross Profit | 769.15B |
| Operating Income | 169.82B |
| Pretax Income | 85.75B |
| Net Income | 75.10B |
| EBITDA | 219.58B |
| EBIT | 169.82B |
| Earnings Per Share (EPS) | 6,526.75 |
Balance Sheet
The company has 164.23 billion in cash and 768.65 billion in debt, giving a net cash position of -604.41 billion or -52,529.10 per share.
| Cash & Cash Equivalents | 164.23B |
| Total Debt | 768.65B |
| Net Cash | -604.41B |
| Net Cash Per Share | -52,529.10 |
| Equity (Book Value) | 953.84B |
| Book Value Per Share | 72,277.28 |
| Working Capital | 71.39B |
Cash Flow
In the last 12 months, operating cash flow was 96.12 billion and capital expenditures -122.69 billion, giving a free cash flow of -26.57 billion.
| Operating Cash Flow | 96.12B |
| Capital Expenditures | -122.69B |
| Free Cash Flow | -26.57B |
| FCF Per Share | -2,309.04 |
Margins
Gross margin is 51.68%, with operating and profit margins of 11.41% and 5.05%.
| Gross Margin | 51.68% |
| Operating Margin | 11.41% |
| Pretax Margin | 5.76% |
| Profit Margin | 5.05% |
| EBITDA Margin | 14.75% |
| EBIT Margin | 11.41% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 600.00, which amounts to a dividend yield of 0.45%.
| Dividend Per Share | 600.00 |
| Dividend Yield | 0.45% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 9.80% |
| Buyback Yield | -0.00% |
| Shareholder Yield | 0.45% |
| Earnings Yield | 4.93% |
| FCF Yield | -1.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 27, 2012. It was a forward split with a ratio of 1.03.
| Last Split Date | Dec 27, 2012 |
| Split Type | Forward |
| Split Ratio | 1.03 |
Scores
KRX:069620 has an Altman Z-Score of 2.28 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.28 |
| Piotroski F-Score | 6 |